Loading...
Cell sources of advanced-therapy medicinal products (ATMPs) : Report and recommendations
Title / Series / Name
Publication Volume
Publication Issue
Pages
Editors
Keywords
URI
https://hdl.handle.net/20.500.14018/26611
Abstract
In Work Package 2, our aim was to answer to the following questions: what 18 are the interactions between EU and national legislation and the procurement of human (embryonic, foetal, and adult) stem cells for research, innovation and therapy and what are the effects of the application and implementation of that legislation on human stem cell procurement. Our main research methods included legal and comparative legal analysis which were applied in an empirical setting reflecting on the scientific and technological state of play in the domain. Our work was carried out with the specific end in mind of informing the Commission of the legal evidence basis that will enable the improvement and the optimisation of the innovative potential, the efficacy and efficiency, and the ethical soundness of future legislation in this area of biomedical research and innovation
Topic
Publisher
Place of Publication
Type
Book chapter
Date
2018
Language
ISBN
9782855989099